Latest news
{{'Thu, 29 Oct 2026 08:00:00 -0400' | dateFormatUsFilter}}
Novo to present new CagriSema and Wegovy® data at ObesityWeek® 2026, including data on treatment experience with Wegovy® pill in the real world
Read more
{{'Wed, 28 Oct 2026 09:03:00 -0400' | dateFormatUsFilter}}
Novo to present new liver data across Wegovy 2.4 mg and investigational efruxifermin at The Liver Meeting® (AASLD) 2026
Read more
{{'Fri, 23 Oct 2026 14:21:00 -0400' | dateFormatUsFilter}}
Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older with type 2 diabetes
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.